TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.4582
-0.0040 (-0.87%)
At close: Apr 4, 2025, 4:00 PM
0.4768
+0.0186 (4.06%)
After-hours: Apr 4, 2025, 4:29 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $10.70 million as of April 4, 2025. Its market cap has increased by 1,367.34% in one year.
Market Cap
10.70M
Enterprise Value
8.16M
1-Year Change
1,367.34%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $10.70M, a decrease of -77.66%. That is a compound annual growth rate of -33.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 10.79M | 359.79% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -52.59% |
| Dec 30, 2022 | 8.72M | -73.34% |
| Dec 31, 2021 | 32.72M | -31.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.59B |
| UnitedHealth Group | 494.35B |
| Johnson & Johnson | 385.14B |
| AbbVie | 356.70B |
| Novo Nordisk | 301.38B |
| AstraZeneca | 231.80B |
| Abbott Laboratories | 228.29B |
| Merck & Co. | 218.22B |